— Know what they know.
Not Investment Advice
Also trades as: LMDXW (NASDAQ) · $vol 0M

LMDX NASDAQ

LumiraDx Limited
1W: +15.1% 1M: +60.0% 3M: -83.2% 1Y: -98.7%
$0.02
Last traded 2025-06-17 — delisted
NASDAQ · Healthcare · Medical - Diagnostics & Research · $5.1M mcap

Balance Sheet Trends

Total Assets
$441M -31.6% ▼
3Y CAGR: +20.9%
Total Liabilities
$546M +13.3% ▲
3Y CAGR: +10.7%
Shareholders Equity
-$105M -164.6% ▼
Cash & Investments
$100M -24.3% ▼
3Y CAGR: -10.5%
Total Debt
$401M +19.4% ▲
Net Debt
$301M +47.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022
— Assets —
Cash$139M$159M$132M$100M
Short-Term Investments$0$0$0$0
Cash & ST Investments$139M$159M$132M$100M
Net Receivables$6M$119M$125M$65M
Inventory$12M$86M$149M$90M
Other Current Assets$23M$13M$20M$50M
Total Current Assets$180M$377M$406M$267M
Property, Plant & Equip.$28M$97M$201M$130M
Goodwill & Intangibles$42M$41M$37M$32M
Long-Term Investments$0$0$0$11M
Other Non-Current Assets-$70M$241K$569K$497K
Total Non-Current Assets$70M$138M$239M$174M
Total Assets$250M$515M$645M$441M
— Liabilities —
Accounts Payable$16M$58M$135M$29M
Short-Term Debt$0$149M$6M$9M
Deferred Revenue$0$46M$40M$8M
Other Current Liabilities$23M$36M-$40M$5M
Total Current Liabilities$39M$289M$141M$92M
Long-Term Debt$360M$149M$330M$389M
Other Non-Current Liab.-$360M$452M$10M$58M
Total Non-Current Liabilities$360M$602M$342M$455M
Total Liabilities$403M$890M$482M$546M
— Equity —
Common Stock$153M$153M$178M$858M
Retained Earnings-$370M-$608M-$677M-$1.1B
Accumulated OCI$0$80M$662M$120M
Total Stockholders Equity-$153M-$375M$163M-$105M
Total Liabilities & Equity$0$515M$645M$441M
— Key Metrics —
Total Debt$0$298M$336M$401M
Net Debt-$139M$139M$204M$301M
Total Investments$0$0$0$11M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms